Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-003068
Filing Date
2010-03-31
Accepted
2010-03-31 16:58:44
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2197674z10-k.htm 10-K 1155354
2 EXHIBIT 21 a2197674zex-21.htm EX-21 2011
3 EXHIBIT 23 a2197674zex-23.htm EX-23 2786
4 EXHIBIT 31.1 a2197674zex-31_1.htm EX-31.1 7654
5 EXHIBIT 31.2 a2197674zex-31_2.htm EX-31.2 7678
6 EXHIBIT 32.1 a2197674zex-32_1.htm EX-32.1 4015
7 EXHIBIT 32.2 a2197674zex-32_2.htm EX-32.2 4035
  Complete submission text file 0001047469-10-003068.txt   1185059
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32325 | Film No.: 10720060
SIC: 2834 Pharmaceutical Preparations